![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RL Peltier, DH Li, D Lytle, CM Taylor and MW Emmett-Oglesby
Department of Pharmacology, University of North Texas HSC at Forth Worth, USA.
These experiments tested the hypothesis that chronic administration of d-amphetamine (d-A) or methamphetamine (METH) would produce cross- tolerance to the discriminative and/or reinforcing effects of cocaine. One group of rats (n = 20) was trained to detect cocaine (10.0 mg/kg; i.p.) from vehicle; cocaine (1.0-17.8 mg/kg) dose dependently substituted for the training dose. Chronic administration of d-A or METH (0.32, 1.0 and 3.2 mg/kg/12 hr for 7 days) resulted in cross- tolerance to the discriminative stimulus effects of cocaine. A second group of rats (n = 12) was implanted with indwelling jugular catheters and were trained to self-administer cocaine under a fixed-ratio 2 schedule of reinforcement. This group of rats also received chronic d-A or METH (0.32, 1.0 and 3.2 mg/kg/12 hr for 7 days. In this group, chronic administration of the highest dose of d-A and of METH (3.2 mg/kg) resulted in cross-tolerance to the self-administration of cocaine. A third group of rats (n = 15) was implanted with indwelling jugular catheters and were trained to self-administer cocaine under a progressive-ratio schedule of reinforcement. Chronic administration of d-A and METH (3.2 mg/kg/12 hr for 7 days) resulted in cross-tolerance to the self-administration of cocaine under this progressive-ratio schedule. The data obtained from these experiments demonstrate that chronic treatment with central nervous system stimulants of the amphetamine type (d-A or METH) produces cross-tolerance to both the discriminative and reinforcing effects of cocaine.
This article has been cited by other articles:
|
|
 |
|
  S. S. Negus, N. K. Mello, B. E. Blough, M. H. Baumann, and R. B. Rothman Monoamine Releasers with Varying Selectivity for Dopamine/Norepinephrine versus Serotonin Release as Candidate "Agonist" Medications for Cocaine Dependence: Studies in Assays of Cocaine Discrimination and Cocaine Self-Administration in Rhesus Monkeys J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 627 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Chang, T. Ernst, O. Speck, and C. S. Grob Additive Effects of HIV and Chronic Methamphetamine Use on Brain Metabolite Abnormalities Am J Psychiatry, February 1, 2005; 162(2): 361 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, Y.-S. Ding, M. Sedler, J. Logan, D. Franceschi, J. Gatley, R. Hitzemann, et al. Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex Focus, April 1, 2003; 1(2): 150 - 157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. D. Langleben, P. D. Acton, G. Austin, I. Elman, G. Krikorian, J. R. Monterosso, O. Portnoy, H. W. Ridlehuber, and H. W. Strauss Effects of Methylphenidate Discontinuation on Cerebral Blood Flow in Prepubescent Boys with Attention Deficit Hyperactivity Disorder J. Nucl. Med., December 1, 2002; 43(12): 1624 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Oyler, E. J. Cone, R. E. Joseph Jr, E. T. Moolchan, and M. A. Huestis Duration of Detectable Methamphetamine and Amphetamine Excretion in Urine after Controlled Oral Administration of Methamphetamine to Humans Clin. Chem., October 1, 2002; 48(10): 1703 - 1714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. D. Volkow, L. Chang, G.-J. Wang, J. S. Fowler, Y.-S. Ding, M. Sedler, J. Logan, D. Franceschi, J. Gatley, R. Hitzemann, et al. Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex Am J Psychiatry, December 1, 2001; 158(12): 2015 - 2021. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
